康泰医学: 关于控股股东、实际控制人股份变动比例触及5%整数倍暨披露简式权益变动报告书的提示性公告

Core Viewpoint - The controlling shareholder and actual controller of Kangtai Medical, Mr. Hu Kun, has reduced his shareholding, but this will not lead to a change in the company's controlling shareholder or actual controller [1]. Group 1: Shareholding Changes - Mr. Hu Kun, holding 188,189,252 shares (46.8362% of total shares), plans to reduce his holdings by up to 4,000,000 shares (0.9955% of total shares) through centralized bidding and up to 8,000,000 shares (1.9910% of total shares) through block trading within three months from the announcement date [2]. - From May 30, 2025, to June 6, 2025, Mr. Hu Kun's shareholding decreased from 46.84% to 45.00%, with a total reduction of 7,377,869 shares [2]. - The reduction consisted of 2,505,869 shares (0.62%) through centralized bidding and 4,872,000 shares (1.21%) through block trading [2]. Group 2: Shareholding Structure Post-Reduction - After the reduction, Mr. Hu Kun holds 180,811,383 shares, with 39,669,444 shares (9.87%) being unrestricted and 141,141,939 shares (35.13%) being restricted [2]. - The total shareholding structure indicates a decrease in unrestricted shares from 47,047,313 (11.71%) to 39,669,444 (9.87%) [2]. Group 3: Compliance and Disclosure - The company confirms that the share reduction complies with relevant regulations and does not violate any commitments made by the shareholder [2]. - The company will continue to monitor the implementation of the share reduction plan and fulfill its disclosure obligations as required by law [2].